MassDevice.com +5 | The top 5 medtech stories for September 28, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Four top medtech stories you need to know in late 2017 The U.S. government continues to create a lot of uncertainty for the medical device industry, but medtech companies are still making some big moves. The frenzy of major mergers continues, which makes sense from an investor standpoint when it comes to reducing risk. Meanwhile, companies from outside the industry – including such high-tech giants as Apple, Google and Microsoft – see medical as a great way to diversify and hedge bets. Read more 4. Dexcom CEO: Bringing meaningful data to the diabetes community Kevin Sayer describes Dexcom‘s history as punctuated by “firsts” – its continuous glucose meter was the first to connect to a phone. Last year, the company’s tool became the first to be approved by the FDA as one from which a patient with diabetes can make insulin dosing decisions. When Sayer took the helm as president & CEO of Dexcom in 2011, he was no stranger to the diabetes space. He served as the CFO of MiniMed from 1994 until it was bought by Medtronic in 2001, at which point he jo...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news